.

Deeper Knowledge, Faster

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents and clinical trials in dozens of countries

► See Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Baxter
Julphar
Fuji
Moodys
McKesson
Queensland Health
McKinsey
Daiichi Sankyo
Johnson and Johnson
US Department of Justice

Generated: June 23, 2017

DrugPatentWatch Database Preview

Belinostat - Generic Drug Details

« Back to Dashboard

What are the generic sources for belinostat and what is the scope of belinostat patent protection?

Belinostat
is the generic ingredient in one branded drug marketed by Spectrum Pharms and is included in one NDA. There are three patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Belinostat has fifty-two patent family members in twenty-seven countries.

There are two drug master file entries for belinostat. One supplier is listed for this compound.

Summary for Generic Name: belinostat

Tradenames:1
Patents:3
Applicants:1
NDAs:1
Drug Master File Entries: see list2
Suppliers / Packagers: see list1
Bulk Api Vendors: see list62
Clinical Trials: see list40
Patent Applications: see list19
Drug Prices:see low prices
DailyMed Link:belinostat at DailyMed

Pharmacology for Ingredient: belinostat

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Spectrum Pharms
BELEODAQ
belinostat
POWDER;IV (INFUSION)206256-001Jul 3, 2014RXYesYes► Subscribe► Subscribe
Spectrum Pharms
BELEODAQ
belinostat
POWDER;IV (INFUSION)206256-001Jul 3, 2014RXYesYes8,835,501► SubscribeY ► Subscribe
Spectrum Pharms
BELEODAQ
belinostat
POWDER;IV (INFUSION)206256-001Jul 3, 2014RXYesYes► Subscribe► Subscribe
Spectrum Pharms
BELEODAQ
belinostat
POWDER;IV (INFUSION)206256-001Jul 3, 2014RXYesYes6,888,027► SubscribeYY ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Non-Orange Book Patents for Generic Ingredient: belinostat

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
7,183,298Carbamic acid compounds comprising a sulfonamide linkage as HDAC inhibitors► Subscribe
7,557,140Carbamic acid compounds comprising a sulfonamide linkage as HDAC inhibitors► Subscribe
7,407,988Carbamic acid compounds comprising a sulfonamide linkage as HDAC inhibitors► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: belinostat

Country Document Number Estimated Expiration
Japan2008540499► Subscribe
Japan5108750► Subscribe
China101189003► Subscribe
Norway339954► Subscribe
CroatiaP20120341► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

US Army
Argus Health
McKinsey
Boehringer Ingelheim
Cerilliant
Express Scripts
Cantor Fitzgerald
Medtronic
Colorcon
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot